AdvaMed® Comment Letter to OIG – January 27, 2023
AdvaMed® responded to HHS OIG’s annual solicitation of proposals for new and modified safe harbors and special fraud alerts.
Legal
Learn more about our Legal work.
AdvaMed® Asks U.S. Supreme Court to Review Arbitrary and Excessive Punishments Resulting From Lack of Clarity in State Law
The Advanced Medical Technology Association® (AdvaMed®) asked the U.S. Supreme Court to review and reverse a California appeals court’s decision imposing over $300 million in penalties on a medical device…
AdvaMed® Asks U.S. Supreme Court to Affirm Government’s Authority to Dismiss Qui Tam Suits
The Advanced Medical Technology Association® (AdvaMed®) has asked the U.S. Supreme Court to affirm a Third Circuit decision that confirms the government’s right to dismiss qui tam suits under the…
AdvaMed® Files Amicus Brief with California Court Opposing New Liability Theory for Products in California Courts
AdvaMed® urged California’s First District Court of Appeal to overturn an erroneous decision by the trial court that has the potential to impose unfair and unwarranted liability upon companies that…
Managing Your Life Sciences Portfolio: False Claims Act Risk for Private Investors and How AdvaMed® Can Help
In recent years, private investors have been subject to increased government enforcement scrutiny under the False Claims Act. Given investors’ vital role in medtech, AdvaMed® developed tools and resources to…
Litigation in the Medical Device Industry
Pat Fogarty sat down with industry observer Jack Kalavritinos for a Q&A to discuss the current landscape of litigation in the medical device industry.
AdvaMed® Best Practice Guidance on Value-Based Arrangements
These arrangements to advance value-based care are designed to increase shared accountability among shareholders for quality of, access to and/or the total cost of care.
Medical Device Mass Tort TV Ad Trends
AdvaMed® publishes a quarterly attorney ad spend tracker, which highlights the amount of money spent on medical device mass tort television advertising.